Related Experiment Videos

Organ-specific carcinogenicity of haloalkenes mediated by glutathione conjugation

W Dekant1, D Henschler

  • 1Department of Toxicology, University of Würzburg, Germany. dekant@toxi.uni-wuerzburg.de

Insights

Halogenated alkenes cause kidney damage through a specific metabolic pathway. This process generates reactive intermediates that may lead to organ toxicity and potential kidney tumors.

Area of Science:

  • Toxicology
  • Metabolism
  • Organic Chemistry

Background:

  • Halogenated alkenes are known nephrotoxins in rodent models.
  • Understanding the mechanism of organ-specific kidney toxicity is crucial for risk assessment.

Purpose of the Study:

  • To elucidate the mechanism of nephrotoxicity induced by halogenated alkenes.
  • To identify the reactive intermediates involved in kidney damage and potential tumorigenicity.

Main Methods:

  • Hepatic glutathione conjugation of halogenated alkenes.
  • Enzymatic cleavage of S-conjugates by gamma-glutamyltransferase and dipeptidases.
  • Substrate analysis of renal cysteine conjugate beta-lyases.

Main Results:

  • Halogenated alkenes are metabolized to cysteine S-conjugates in the liver.
  • Renal cysteine conjugate beta-lyases cleave these conjugates to form reactive thioketenes or thionoacyl halides.
  • N-acetylation leads to excretable mercapturic acids, representing an alternative pathway.

Conclusions:

  • The formation of reactive intermediates by cysteine-conjugate beta-lyase is a key mechanism for halogenated alkene nephrotoxicity.
  • These reactive intermediates may contribute to target-organ toxicity and potential renal tumorigenicity.
  • The findings are relevant to widely used chlorinated olefins in chemical processes.

Related Concept Videos